Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Mereo BioPharma's price to book ratio was 1.7× on Nov 11, 2026, against 6.3× a year earlier. Over the last 5 years it ranged from 0.6× to 12.9×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.7× | +0.3 |
| 2025 | Dec 31, 2025 | 1.4× | −6.2 |
| 2024 | Oct 31, 2024 | 7.6× | +2.2 |
| 2023 | Dec 29, 2023 | 5.4× | +4.5 |
| 2022 | Dec 30, 2022 | 0.9× | – |
See a number that looks wrong?